Butterflies Healthcare has released the Viteyes 2 supplement, which it said contained the exact formula recommended in the AREDS2 trial. ‘While the results from the study were not as ground-breaking as some people had hoped, it still points the way for the most appropriate care for patients with early AMD. It reaffirmed that specific high dose vitamins combined with lutein and zeaxanthin can help slow the progression of macular degeneration,’ a spokesperson for Butterflies Healthcare said.
? DETAILS: 0845 838 6704.
Register now to continue reading
Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.
Register
Already have an account? Sign in here
